Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Avon Rejects Coty's Offer - Quick Facts

RELATED NEWS
Trade AVP now with 

Beauty company Avon Products, Inc. (AVP: Quote) on Monday rejected an an unsolicited, non-binding indication of interest from Coty Inc. to acquire Avon for $23.25 per share.

Coty's indication of interest is non-binding and subject to several conditions such as financing, due diligence and the negotiation of a definitive agreement.

Avon said Coty is attempting to obtain a "free look" at Avon in the absence of any commitment whatsoever to close a transaction at any price.

"Coty's indication of interest of $23.25 per share does not provide a compelling reason for Avon to deviate from its current plans. Under the circumstances, Avon's Board is convinced that rejecting Coty's indication of interest is in Avon shareholders' best interests," the company said.

Avon said its Board of Directors carefully considered the indication of interest from Coty that was substantially the same as one made less than two weeks ago. At that time, the Board concluded, and it still believes, that Coty's indication of interest is opportunistic and not in the best interest of Avon's shareholders.

The Avon Board believes Coty's indication of interest, which offers Avon shareholders only a 20 percent premium over the company's closing share price on March 30, does not reflect the fundamental value of Avon and its global beauty care franchise.

Avon said it is committed to its process of hiring a new CEO and executing against its strong long-term prospects. Avon's Board firmly believes that with a new CEO, there is greater opportunity to improve shareholder value in excess of Coty's conditional indication of interest.

Register
To receive FREE breaking news email alerts for Avon Products and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.